Aldactone is a potassium-sparing diuretic containing spironolactone. It is prescribed for adults who need treatment for fluid retention, heart failure, resistant hypertension, or excess aldosterone. By blocking aldosterone, it helps the body remove sodium and water while retaining potassium.
Aldactone is a spironolactone tablet used to reduce fluid retention and treat conditions linked to excess aldosterone, including certain cases of heart failure and high blood pressure. Each tablet contains spironolactone, which helps the body remove sodium and water while retaining potassium. Spironolactone is a potassium-sparing diuretic and an aldosterone antagonist. The dose is stated on the pack — follow the leaflet.
Aldactone contains spironolactone per tablet. Spironolactone is a potassium-sparing diuretic and an aldosterone antagonist. Aldosterone is a hormone that tells the kidneys to retain sodium and water; spironolactone blocks this signal.
The result is less fluid accumulation and reduced strain on the heart and blood vessels. Unlike loop diuretics, spironolactone does not usually cause potassium loss. That benefit also explains its main safety issue: potassium can rise too high.
Aldactone tablets are taken orally. The prescribed daily dose depends on the condition being treated, kidney function, blood pressure, potassium level, and other medicines used at the same time. The dose is stated on the pack — follow the leaflet.
For some conditions, the stated dose may be the full daily dose. For others, clinicians may use a lower starting dose or divide the total daily dose. Heart failure treatment often starts at lower doses than treatment for primary hyperaldosteronism or marked oedema.
Aldactone is often taken for an extended period, depending on the reason for treatment. Blood pressure reduction may take time. Reduced swelling can appear sooner, yet the timing varies with the underlying condition and fluid intake.
One common mistake is adding potassium supplements independently because the person assumes every diuretic lowers potassium. Aldactone does the opposite. Potassium supplements and potassium-based salt substitutes can create a dangerous rise in blood potassium.
Spironolactone works in the distal tubules of the kidneys. These are the parts of the kidney that fine-tune sodium, water, and potassium balance. By blocking mineralocorticoid receptors, Aldactone reduces aldosterone-driven sodium retention.
Less sodium stays in the body. Water follows sodium, so swelling and fluid pressure can reduce. Potassium is retained, which distinguishes spironolactone from diuretics such as furosemide.
In heart failure, aldosterone can contribute to fluid overload, fibrosis, and harmful changes in the heart muscle. The RALES trial found that adding spironolactone to standard treatment in severe heart failure reduced mortality and hospitalisation risk, though laboratory monitoring remained essential because potassium levels may rise [2].
Aldactone also has mild anti-androgen activity. This can help some women with acne or unwanted facial hair. It can also cause breast tenderness, menstrual changes, or reduced libido in some users.
Aldactone may be prescribed for:
The FDA-approved prescribing information identifies hyperkalaemia, meaning high blood potassium, as the key dose-related risk of spironolactone treatment [1].
Aldactone is chosen when aldosterone blockade or potassium conservation is clinically useful. The best alternative depends on whether the main target is fluid overload, resistant hypertension, heart failure, or hormonal symptoms.
| Treatment approach | Main action | Practical difference |
|---|---|---|
| Spironolactone | Blocks aldosterone and retains potassium | Useful for aldosterone-related fluid retention, resistant hypertension, and selected heart failure |
| Loop diuretic | Promotes strong sodium and water removal | Often used for significant swelling; may lower potassium |
| Thiazide-type diuretic | Reduces sodium reabsorption in the kidney | Common for blood pressure control; may lower potassium and sodium |
For resistant hypertension, spironolactone has strong evidence as an added treatment after standard blood-pressure medicines have not achieved control. In the PATHWAY-2 trial, spironolactone lowered home systolic blood pressure more than other add-on options in people with resistant hypertension [3].
The trade-off is monitoring. A loop diuretic may act more strongly for rapid fluid reduction, while Aldactone is more targeted toward aldosterone activity. Spironolactone can be a poor fit when potassium is already high or kidney filtration is severely reduced.
Aldactone is not for you if you have hyperkalaemia, Addison’s disease, or anuria, meaning the kidneys are not producing urine. It is also unsuitable when spironolactone has previously caused a serious allergic reaction.
Extra caution is required with impaired kidney function. The risk of potassium accumulation increases when kidney filtration is reduced, especially if Aldactone is combined with other medicines that raise potassium.
Do not combine Aldactone without prescriber approval with:
Pregnancy planning also needs individual clinical review. Spironolactone’s anti-androgen activity raises concern for fetal development, so it is generally avoided in pregnancy unless a specialist determines otherwise.
The WHO Model List of Essential Medicines includes spironolactone for specific clinical uses, reflecting its established role when patients are selected and monitored appropriately [4].
Aldactone may not be suitable if you have high potassium, severe kidney problems, Addison’s disease, or if your kidneys are not producing urine. Tell your prescriber if you have ever had a serious allergic reaction to spironolactone. Do not start potassium supplements, potassium-based salt substitutes, or interacting medicines without medical advice.
If you are planning a pregnancy or may be pregnant, discuss Aldactone with a clinician because its hormone-related activity may affect fetal development. Mention every regular medicine, including painkillers bought without prescription and potassium-containing supplements, before starting Aldactone.
Most people tolerate spironolactone without severe problems when the dose and blood tests are managed carefully. Increased urination, dizziness, nausea, diarrhoea, abdominal discomfort, headache, and tiredness can occur.
The most clinically important adverse effect is hyperkalaemia. Mild hyperkalaemia may cause no obvious symptoms. Marked elevation can affect heart rhythm and may cause weakness, tingling, palpitations, or an irregular heartbeat.
Hormonal side effects can occur because spironolactone also interacts with androgen and progesterone receptors. These may include:
Dizziness deserves attention. It can reflect reduced blood pressure, dehydration, or an interaction with another blood-pressure medicine. Standing up slowly is sensible during the first days of treatment or after a dose adjustment.
Persistent vomiting, severe diarrhoea, marked weakness, fainting, very slow pulse, or palpitations need prompt medical assessment. These symptoms can signal dehydration, low blood pressure, or an electrolyte disturbance.
Problems with spironolactone often come from interactions or incorrect assumptions, not from the tablet itself.
Another practical issue is weighing oneself inconsistently when Aldactone is prescribed for fluid retention. A sudden, sustained weight increase can be more meaningful than a single day of mild ankle swelling. Record weight under similar conditions, such as after waking and using the toilet.
In clinical practice, doctors usually view Aldactone as a targeted medicine rather than a general diuretic. It is valuable when aldosterone is part of the problem: resistant blood pressure, fluid retention with heart failure, or primary hyperaldosteronism are common examples.
Doctors usually set expectations around monitoring from the beginning. Kidney function and potassium testing are not administrative extras. They determine whether the medicine remains appropriate at the current dose.
A useful clinical observation is that swelling and body weight can improve while potassium rises without symptoms. That is why feeling well does not replace scheduled blood tests. NAFDAC medicines oversight and the broader safety standards used by bodies such as the EMA support the same principle: benefit and monitoring must travel together.
Aldactone can be very helpful, but it is not the preferred option for every type of swelling. Swelling caused by a blood clot, severe infection, or untreated venous disease needs the underlying cause addressed rather than automatic diuretic use.
Aldactone begins affecting kidney sodium handling after it is absorbed, yet the noticeable benefit depends on the condition. Increased urination can occur within days, while blood-pressure or heart-failure benefits may build over several weeks. The 2023 FDA prescribing information describes spironolactone as an aldosterone antagonist with effects that require dose selection and laboratory follow-up. Do not increase the dose because early results seem slow.
Yes. High potassium is the main safety concern with spironolactone, especially in people with kidney impairment or those taking ACE inhibitors, angiotensin receptor blockers, potassium supplements, or certain antibiotics. Symptoms may include weakness, tingling, nausea, palpitations, or an irregular heartbeat, though some people have no symptoms. WHO guidance from 2023 on essential medicines recognises spironolactone’s place in treatment while clinical use requires appropriate monitoring. Blood tests are the reliable way to detect this problem.
Aldactone tablets can be taken with food if this improves stomach comfort. Taking it consistently in relation to meals can make the routine easier to maintain. Food does not remove the need to monitor potassium or kidney function. The 2023 FDA label advises clinicians to consider interacting medicines and electrolyte status throughout treatment.
Yes, spironolactone is widely used as an add-on treatment for resistant hypertension after standard medicines have not provided adequate control. The PATHWAY-2 study, published in The Lancet in 2015, found spironolactone more effective than several alternative add-on strategies for home blood-pressure reduction . It is not automatically suitable for every person with high blood pressure. Potassium and kidney function guide whether it can be used safely.
Men can take Aldactone for heart failure, fluid retention, high blood pressure, and hyperaldosteronism when prescribed. Spironolactone may cause breast enlargement, breast tenderness, reduced libido, or erectile difficulties because of its hormone-related effects. These effects are dose-related in some patients and should be reported rather than silently tolerated. FDA safety information from 2023 lists gynaecomastia among recognised adverse reactions.
Clinicians commonly assess potassium and kidney function before treatment and again after starting or changing the dose. Blood pressure, body weight, ankle swelling, and symptoms of dehydration may also be reviewed. NICE guidance from 2018 on chronic heart failure includes mineralocorticoid receptor antagonists within monitored treatment pathways because renal function and potassium can change during therapy [5]. The frequency of testing depends on the indication, dose, age, kidney health, and other medicines.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
